CREON 1236 (Creon 180,000 units amylase / 36,000 units lipase / 114,000 units protease)

Generic Name: pancrelipase

Pill imprint CREON 1236 has been identified as Creon 180,000 units amylase / 36,000 units lipase / 114,000 units protease.

Creon is used in the treatment of chronic pancreatitis; pancreatic exocrine dysfunction; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Creon 180,000 units amylase / 36,000 units lipase / 114,000 units protease is not a controlled substance under the Controlled Substance Act (CSA).

Creon

Generic Name:

pancrelipase

Imprint:

CREON 1236

Strength:

180,000 units amylase / 36,000 units lipase / 114,000 units protease

Color:

Blue / Clear

Shape:

Capsule-shape

Availability:

Rx and/or OTC

Drug Class:

Digestive enzymes

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

AbbVie, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.